# OnCo record rectal-cancer (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/rectal-cancer/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "rectal-cancer" ;
  schema:name "Rectal cancer"@en ;
  schema:alternateName "Rectal adenocarcinoma"@en, "Cancer of the rectum"@en, "Locally advanced rectal cancer"@en, "Rectum cancer"@en ;
  schema:description "Rectal cancer is bowel cancer in the last part of the large intestine, where surgery can mean a permanent stoma. Treatment now usually gives all the chemotherapy and radiotherapy first, and about half of people whose tumour disappears completely can keep their rectum and avoid surgery altogether."@en ;
  schema:url <https://onco.cc/cancers/rectal-cancer/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Colorectal_cancer> ;
  schema:citation <https://en.wikipedia.org/wiki/Colorectal_cancer>, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1461> ;
  onco:tag "subtype-page" ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:pathways <https://onco.cc/pathways/colorectal-cancer-signalling/> ;
  onco:terms <https://onco.cc/terms/total-neoadjuvant-therapy/>, <https://onco.cc/terms/organ-preservation/>, <https://onco.cc/terms/clinical-complete-response/>, <https://onco.cc/terms/total-mesorectal-excision/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/stoma/>, <https://onco.cc/terms/msi/> ;
  onco:trials <https://onco.cc/trials/rapido/>, <https://onco.cc/trials/prodige-23/>, <https://onco.cc/trials/opra/>, <https://onco.cc/trials/prospect/>, <https://onco.cc/trials/cao-aro-aio-94/>, <https://onco.cc/trials/azur-1/>, <https://onco.cc/trials/nct06640049/> ;
  onco:people <https://onco.cc/people/angelita-habr-gama/>, <https://onco.cc/people/julio-garcia-aguilar/>, <https://onco.cc/people/andrea-cercek/>, <https://onco.cc/people/luis-diaz/> ;
  onco:pipeline <https://onco.cc/trials/azur-1/>, <https://onco.cc/trials/nct06640049/>, <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/drugs/signatera/>, <https://onco.cc/ideas/idea-ctdna-guided-adjuvant-crc/> ;
  onco:standardOfCare <https://onco.cc/terms/total-mesorectal-excision/>, <https://onco.cc/technologies/robotic-surgery/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/trials/rapido/>, <https://onco.cc/trials/prodige-23/>, <https://onco.cc/trials/opra/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/terms/total-neoadjuvant-therapy/>, <https://onco.cc/terms/organ-preservation/>, <https://onco.cc/terms/clinical-complete-response/>, <https://onco.cc/trials/prospect/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/total-mesorectal-excision/>, <https://onco.cc/drugs/dostarlimab/>, <https://onco.cc/trials/azur-1/>, <https://onco.cc/terms/msi/>, <https://onco.cc/terms/organ-preservation/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/terms/hepatectomy/> .